The Brain & Mind Experts

We specialize in the diagnosis, treatment and care of people with Alzheimer’s disease, dementia, cognitive impairment or mental health concerns.

Our international clinics are global-leaders in providing volunteers with access to new treatments for Alzheimer’s disease, free of charge. We are delighted to be members of the Global Alzheimer Platform Foundation and are committed to providing excellent patient-centric care.

Visit Re:Cognition Health UK

Memory Studies available for memory loss and Alzheimer’s disease

We provide access to ground-breaking Alzheimer’s disease treatments through clinical trials.

New medications for memory loss and Alzheimer’s disease are available in international memory studies, which are being conducted across the globe.

With more than 5.7 million people living with a diagnosis of mild cognitive impairment or dementia in the United States, we are committed to providing individuals with access to pioneering disease-modifying medications.

The drugs available in the different Alzheimer’s memory studies each work in different ways. This is called the ‘mechanism of action’.  As part of the initial enrollment process, our expert team will discuss all of the memory studies available at our research center, ensuring you are fully informed and matched to the memory study most appropriate for you.

Our clinical team is very involved in the enrollment process. They are available to discuss the key requirements of the study and to educate volunteers on the different investigations and medical procedures that take place throughout the study. All of the care provided is at no cost to the volunteer. We will also reimburse reasonable travel expenses for each of your visits.

For more information, simply complete the form below.

Benefits of Alzheimer’s research

  • Volunteering for a study helps the development of new Alzheimer’s drugs.
  • At no charge, participants have access to world-class medical care and to new Alzheimer’s medication.
  • Participants also receive comprehensive medical monitoring and investigations at no charge. Safety is our top priority. Contribute to the advancement of scientific knowledge. Join a thriving community of volunteers championing the development of Alzheimer’s research and raising awareness for Alzheimer’s and dementia research.

Memory loss clinical trial

Register for an Alzheimer’s Research Trial

The enrollment process is simple and is managed by our dedicated patient coordinators. Our expert team will communicate with you at each stage of the process and keep you fully-informed at all times. Simply complete the short registration form and one of our patient coordinators will be in touch to explain the memory studies in further detail.

USA Clinical Trials Registration

  • Please let us know a little about your memory concerns, any medications that you are taking and any health issues. If you'd prefer not to disclose this information here, please let us know by writing 'I'd prefer to discuss over the phone'

Meet Our Team

Dr. James Bicksel, MD
Principal Investigator

Dr. James Bicksel, MD

Principal Investigator

Bio

  • Dr. James Bicksel, Clinical Lead of Re:Cognition Health Fairfax County, is board certified in Neurology and Clinical Neurophysiology by the American Board of Neurology and Psychiatry. He is also certified in Behavioral Neurology and Neuropsychiatry by the United Council for Neurologic Subspecialties.
  • Dr. Bicksel is on the medical staff of Inova Fairfax Hospital where he serves as Medical Director of the Inova Memory Center and is also on the Ethics Committee.
  • As medical director of Inova Memory Center, he has lectured extensively throughout the Washington, DC area. Dr. Bicksel has served on the board of directors of the Alzheimer’s Association for the National Capital Area chapter.

Mary F. Weiss LPN CCRC
Study Coordinator

Mary F. Weiss LPN CCRC

Study Coordinator

Bio

Mary F. Weiss has been a licensed nurse for over 30 years. She began working in trials over 20 years ago as a coordinator for diabetes trials. She is certified in clinical research and in 2006 Mary opened her own clinical trial site and has conducted over 75 clinical trials in various indications with training and over 15 master program students seeking experience in research.

Whitney Mislock
Cognitive Rater

Whitney Mislock

Cognitive Rater

Bio

Whitney Mislock is a Speech Language Pathologist who specializes in communicative and cognitive deficits in adults with Alzheimer’s disease and other dementias, as well as those recovering from stroke and brain injury. Whitney has experience in acute, inpatient, and outpatient rehabilitation settings, providing assessment and treatment to patients, and facilitating family involvement and education. In her current role as Rater/Clinical Trials Associate at Re:Cognition Health Fairfax, Whitney screens and evaluates cognition to determine trial eligibility and assess cognitive status throughout clinical trials.

Kieran J. Maestro, M.S.
Cognitive Rater

Kieran J. Maestro, M.S.

Cognitive Rater

Bio

Kieran J. Maestro, M.S., is a doctoral candidate in Counseling Psychology currently working toward the completion of his degree.  At Re:Cognition Health, Kieran is delighted to facilitate participants’ involvement in cutting edge research designed to work toward the eradication of Alzheimer’s Disease and other forms of age-related cognitive decline.  Kieran provides both administrative and cognitive rating support at Re:Cognition Health.

Victoria Mantyla, M.S.
Cognitive Rater

Victoria Mantyla, M.S.

Cognitive Rater

Bio

Victoria Mantyla, M.S. obtained her Masters Degree in Psychology and has worked extensively in the Research Industry for over a decade as both a Psychometrician and a Clinical Research Associate. She also had led Caregiver Support Groups and performed Community Lectures for Alzheimers Disease in clinical settings and with the Alzheimers Association.

As a Cognitive Rater with Re:Cognition Health, she conducts interviews and administers various neuropsychological assessments.

Meet our team at a free presentation

We understand joining a memory study is a big commitment. That's why we are dedicated to ensuring you are completely comfortable with all of the requirements, commitments and details related to the study. If you would like to speak with a member of our team in person, register for one of our free presentations. Simply complete the short form below and we will be in touch to confirm your registration. Presentations typically take place at our clinic: 8316 Arlington Blvd., Suite 420, Fairfax, VA 22031. We look forward to meeting you!

USA Events Registration

  • All events will take place at our clinic: 8316 Arlington Boulevard, Suite 420, Fairfax, VA 22031

FAQs

Q) Will I be paid?

A) Volunteers are not paid for taking part in this Alzheimer's research. However, the sponsor will reimburse reasonable travel expenses for you and your study partner for each visit.

Q) What is a study partner and why do I need one?

A) A study partner is someone who accompanies the participant to some study visits and can answer questions about the volunteer’s symptoms. The study partner should be someone who sees the volunteer regularly (e.g., a spouse, relative or close friend) as they will need to inform us about any potential changes in the volunteer’s health or behavior. The number of visits he or she needs to attend depends on each study.

Q) How often are the visits?

A) This depends on the research study. The screening portion of the study is generally when the visits are most frequent. This is when all initial screening is conducted to confirm whether a volunteer is eligible for a study. During the treatment stage of the study, the visits will be less frequent. Some studies require a clinic visit once a month; other studies require a visit every six weeks. If you enroll in a study, we will be able to give you all of your appointments in advance. 

Q) Can I take part if I have vascular dementia?

A) Unfortunately all of the current studies are for Alzheimer’s disease. However, we are always activating new Alzheimer's research studies, so please make sure to connect with our team using the contact form so we can keep you updated.

Q) Will I have to take a trial drug?

A) Yes. If you are eligible for one of the clinical trials, you will consent to be assigned to a treatment group. Depending on the trial, the trial medication may be in the form of a tablet taken orally once a day or an intravenous infusion once a month.

Q) Will I know what I am taking?

A) No. You will not know whether you are taking the active study drug or a placebo. A placebo is a similar looking tablet, but doesn't contain any active drug. You will be randomly assigned to a study groups and you and your study team will not know which group you are in. This is called a randomised, double-blind, placebo controlled trial.

Q) What if I am in the placebo group?

A) There is a chance you will be in the placebo group. The probability will depend on the trial and will range from a 50% to a 30% placebo group. Whichever group you are in, you will still benefit from the ongoing medical care and psychometric testing you will receive as part of the trial. At the end of the trial period, most trials offer the opportunity for you to enter the “open label extension”. This is when you continue in the trial on the active drug despite whichever group (placebo or active drug) you were in previously. The open label extension is un-blinded, so you will know you are on the active drug.

Q) Are there any side effects?

A) Any potential side effects will be listed in the patient information sheets sent to you prior to your initial consultation. Most side effects are non-specific, but some trials have specific side effects that your study doctor will discuss with you. If you have a primary care physician, we will work closely with him or her – and you – to ensure your safety at all times.

Q) Can I leave a trial before it concludes?

A) Absolutely. Leaving a study does not affect your medical or legal rights. And it is not necessary to give us a reason as to why you want to leave, although we always value any feedback. If you choose to leave after you have started taking the study drug, we are obligated to offer you a closing visit to carry out final medical investigations to ensure your safety.

Contact Us

8316 Arlington Boulevard
Suite 420
Fairfax, VA
22031

hello@re-cognitionhealth.com

(703)-520-9703